We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
APA Corp
APA
$12.7B
| $90K | ﹤0.01% |
4,954
-44,665
| -90% | -$775K |
|
1677
Rush Street Interactive
RSI
$2.9B
| $90K | ﹤0.01% |
+6,102
| New | +$75.7K |
|
|
DAWN
1678
DELISTED
Day One Biopharmaceuticals
DAWN
| $89K | ﹤0.01% |
+13,765
| New | +$94.7K |
|
1679
Murphy USA
MUSA
$10.9B
| $89K | ﹤0.01% |
219
-1,999
| -90% | -$909K |
|
1680
Sanara MedTech
SMTI
$313M
| $89K | ﹤0.01% |
3,160
+3,155
| +63,100% | +$94.6K |
|
1681
Wabtec
WAB
$50.1B
| $89K | ﹤0.01% |
430
-200
| -32% | -$38.5K |
|
1682
Bloomin' Brands
BLMN
$764M
| $88K | ﹤0.01% |
10,378
+6,646
| +178% | +$53.4K |
|
1683
Herbalife
HLF
$1.33B
| $88K | ﹤0.01% |
10,234
-172,187
| -94% | -$1.28M |
|
1684
Butterfly Network
BFLY
$2.35B
| $87K | ﹤0.01% |
43,693
+21,879
| +100% | +$50.2K |
|
1685
Brookdale Senior Living
BKD
$3.4B
| $87K | ﹤0.01% |
12,531
+3,644
| +41% | +$23.7K |
|
1686
RE/MAX Holdings
RMAX
$195M
| $87K | ﹤0.01% |
10,679
-3,412
| -24% | -$26.5K |
|
1687
Dillards
DDS
$9.65B
| $86K | ﹤0.01% |
208
+100
| +93% | +$37.3K |
|
1688
Lifeway Foods
LWAY
$452M
| $86K | ﹤0.01% |
3,518
-5,076
| -59% | -$120K |
|
1689
Insulet
PODD
$11.6B
| $86K | ﹤0.01% |
276
-4,473
| -94% | -$1.29M |
|
1690
GoodRx Holdings
GDRX
$1.13B
| $85K | ﹤0.01% |
17,142
+5,201
| +44% | +$22.6K |
|
1691
Bruker
BRKR
$7.66B
| $84K | ﹤0.01% |
2,056
-29,124
| -93% | -$1.12M |
|
1692
Tennant Co
TNC
$1.46B
| $84K | ﹤0.01% |
1,092
-75
| -6% | -$5.54K |
|
1693
Capital City Bank Group
CCBG
$902M
| $82K | ﹤0.01% |
2,104
-13
| -0.6% | -$479 |
|
1694
GlobalFoundries
GFS
$28.5B
| $82K | ﹤0.01% |
2,164
| – | – |
|
1695
Gossamer Bio
GOSS
$88.7M
| $82K | ﹤0.01% |
67,362
+23,601
| +54% | +$25.7K |
|
1696
Loews
L
$23.8B
| $82K | ﹤0.01% |
900
| – | – |
|
1697
Lincoln National
LNC
$9B
| $81K | ﹤0.01% |
2,363
-1,091
| -32% | -$35.7K |
|
1698
Nu Skin
NUS
$251M
| $81K | ﹤0.01% |
10,138
| – | – |
|
1699
ProShares Russell 2000 Dividend Growers ETF
SMDV
$710M
| $81K | ﹤0.01% |
1,250
| – | – |
|
1700
Flowers Foods
FLO
$1.55B
| $80K | ﹤0.01% |
5,060
+450
| +10% | +$7.76K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.